COO vs ONCO · P/E 36, rev $4.09B vs P/E 0.0, rev $815.4K
The Cooper Companies, Inc (COO) versus Onconetix Inc (ONCO) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported ONCO revenue for 2025-12-31 was $815.4K. Net income was -$14.0M. Revenue was down 67.7% from 2024-12-31 to 2025-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
COO currently screens at market cap $14.92B and trailing P/E 36.1. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
Not investment advice. Open the COO and ONCO stock pages for the full models.
Not investment advice.